Provided by Tiger Trade Technology Pte. Ltd.

Biomea Fusion, Inc.

1.14
+0.05004.59%
Post-market: 1.13-0.0100-0.88%19:41 EDT
Volume:984.90K
Turnover:1.11M
Market Cap:80.60M
PE:-0.52
High:1.16
Open:1.15
Low:1.10
Close:1.09
52wk High:3.08
52wk Low:0.8719
Shares:70.70M
Float Shares:57.24M
Volume Ratio:0.76
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2050
EPS(LYR):-3.8339
ROE:-209.00%
ROA:-75.23%
PB:5.16
PE(LYR):-0.30

Loading ...

Biomea Fusion Announces Oral Presentation of Icovamenib at the 23Rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (Wcirdc)

THOMSON REUTERS
·
Dec 02, 2025

Biomea Fusion Grants Stock Options to New Employee Under 2023 Inducement Plan

Reuters
·
Dec 02, 2025

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Dec 02, 2025

Biomea Fusion to Join Piper Sandler and Evercore Healthcare Investor Conferences

Reuters
·
Nov 24, 2025

JPMorgan Downgrades Biomea Fusion to Underweight From Neutral

MT Newswires Live
·
Nov 17, 2025

U.S. RESEARCH ROUNDUP- Applied Materials, Blackstone Mortgage, Brookdale Senior Living

Reuters
·
Nov 17, 2025

Biomea Fusion Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS
·
Nov 17, 2025

Biomea Fusion downgraded to Underweight from Neutral at JPMorgan

TIPRANKS
·
Nov 15, 2025

Biomea Fusion Is Maintained at Buy by Citigroup

Dow Jones
·
Nov 11, 2025

Biomea Fusion Inc. to Present at Jefferies London Healthcare Conference

Reuters
·
Nov 10, 2025

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Nov 05, 2025

Biomea Fusion Launches Phase I Trial of Oral GLP-1 Agonist BMF-650 for Obesity

Reuters
·
Nov 05, 2025

H.C. Wainwright Sticks to Its Buy Rating for Biomea Fusion (BMEA)

TIPRANKS
·
Nov 05, 2025

Biomea Fusion Inc. Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 05, 2025

Biomea Fusion Q3 EPS $(0.27) Misses $(0.26) Estimate

Benzinga
·
Nov 05, 2025

Biomea Fusion Q3 net loss narrows

Reuters
·
Nov 05, 2025

Biomea Fusion Reports Q3 2025 Results and Extends Cash Runway Into 2027

Reuters
·
Nov 05, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 04, 2025

Biomea Fusion’s BMF-650: A New Hope in Obesity Treatment?

TIPRANKS
·
Nov 01, 2025

Biomea Fusion Unveils Preclinical Data on Oral GLP-1 Agonist and Menin Inhibitor Combination at ObesityWeek 2025

Reuters
·
Oct 30, 2025